{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:23:18Z","timestamp":1791973398534,"version":"4.4.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T00:00:00Z","timestamp":1470268800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s11914-016-0317-0","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T05:31:22Z","timestamp":1470288682000},"page":"178-186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":129,"title":["Fibrous Dysplasia\/McCune-Albright Syndrome: Clinical and Translational Perspectives"],"prefix":"10.1007","volume":"14","author":[{"given":"Cemre","family":"Robinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Boyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,4]]},"reference":[{"key":"317_CR1","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/archsurg.1938.01190230153012","volume":"36","author":"L Lichtenstein","year":"1938","unstructured":"Lichtenstein L. Polyostotic fibrous dysplasia. Arch Surg. 1938;36:874\u201398.","journal-title":"Arch Surg"},{"issue":"24","key":"317_CR2","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM199112123252403","volume":"325","author":"LS Weinstein","year":"1991","unstructured":"Weinstein LS et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med. 1991;325(24):1688\u201395.","journal-title":"N Engl J Med"},{"issue":"3","key":"317_CR3","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s11914-015-0268-x","volume":"13","author":"S Turan","year":"2015","unstructured":"Turan S, Bastepe M. GNAS spectrum of disorders. Curr Osteoporos Rep. 2015;13(3):146\u201358.","journal-title":"Curr Osteoporos Rep"},{"issue":"6297","key":"317_CR4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/348125a0","volume":"348","author":"HR Bourne","year":"1990","unstructured":"Bourne HR, Sanders DA, McCormick F. The GTPase superfamily: a conserved switch for diverse cell functions. Nature. 1990;348(6297):125\u201332.","journal-title":"Nature"},{"key":"317_CR5","doi-asserted-by":"crossref","unstructured":"Riminucci M. et al. Fibrous dysplasia as a stem cell disease. J Bone Miner Res, 2006. 21 Suppl 2: p. P125-31.","DOI":"10.1359\/jbmr.06s224"},{"issue":"5","key":"317_CR6","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1359\/jbmr.091036","volume":"25","author":"S Piersanti","year":"2010","unstructured":"Piersanti S et al. Transfer, analysis, and reversion of the fibrous dysplasia cellular phenotype in human skeletal progenitors. J Bone Miner Res. 2010;25(5):1103\u201316.","journal-title":"J Bone Miner Res"},{"issue":"4","key":"317_CR7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1399-0004.1986.tb01261.x","volume":"29","author":"R Happle","year":"1986","unstructured":"Happle R. The McCune-Albright syndrome: a lethal gene surviving by mosaicism. Clin Genet. 1986;29(4):321\u20134.","journal-title":"Clin Genet"},{"issue":"2","key":"317_CR8","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ajmg.1320410217","volume":"41","author":"M Endo","year":"1991","unstructured":"Endo M et al. Monozygotic twins discordant for the major signs of McCune-Albright syndrome. Am J Med Genet. 1991;41(2):216\u201320.","journal-title":"Am J Med Genet"},{"issue":"6","key":"317_CR9","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0022-3476(77)80898-6","volume":"91","author":"L Lemli","year":"1977","unstructured":"Lemli L. Fibrous dysplasia of bone. Report of female monozygotic twins with and without the McCune-Albright syndrome. J Pediatr. 1977;91(6):947\u20139.","journal-title":"J Pediatr"},{"issue":"4","key":"317_CR10","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1210\/jc.2013-3647","volume":"99","author":"R Peleg","year":"2014","unstructured":"Peleg R, Treister-Goltzman Y. Images in clinical medicine: McCune-Albright syndrome. J Clin Endocrinol Metab. 2014;99(4):1105\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"317_CR11","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1172\/JCI2361","volume":"101","author":"P Bianco","year":"1998","unstructured":"Bianco P et al. Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsalpha-mutated skeletal progenitor cells. J Clin Invest. 1998;101(8):1737\u201344.","journal-title":"J Clin Invest"},{"issue":"2","key":"317_CR12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/(SICI)1096-9896(199901)187:2<249::AID-PATH222>3.0.CO;2-J","volume":"187","author":"M Riminucci","year":"1999","unstructured":"Riminucci M et al. The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: site-specific patterns and recurrent histological hallmarks. J Pathol. 1999;187(2):249\u201358.","journal-title":"J Pathol"},{"key":"317_CR13","doi-asserted-by":"crossref","unstructured":"Collins MT, Riminucci M, Bianco P. Fibrous dysplasia. In: Rosen C, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. 8th ed. Washington, DC: American Society of Bone and Mineral Research: p. 2013: 786\u2013793.","DOI":"10.1002\/9781118453926.ch94"},{"issue":"9","key":"317_CR14","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1359\/jbmr.070511","volume":"22","author":"ES Hart","year":"2007","unstructured":"Hart ES et al. Onset, progression, and plateau of skeletal lesions in fibrous dysplasia and the relationship to functional outcome. J Bone Miner Res. 2007;22(9):1468\u201374.","journal-title":"J Bone Miner Res"},{"issue":"5","key":"317_CR15","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1007\/s11999-013-3380-1","volume":"472","author":"E Ippolito","year":"2014","unstructured":"Ippolito E et al. Radiographic classification of coronal plane femoral deformities in polyostotic fibrous dysplasia. Clin Orthop Relat Res. 2014;472(5):1558\u201367.","journal-title":"Clin Orthop Relat Res"},{"issue":"4","key":"317_CR16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1359\/JBMR.0301262","volume":"19","author":"AI Leet","year":"2004","unstructured":"Leet AI et al. Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome. J Bone Miner Res. 2004;19(4):571\u20137.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"317_CR17","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2106\/00004623-200403000-00011","volume":"86-A","author":"AI Leet","year":"2004","unstructured":"Leet AI et al. Fibrous dysplasia in the spine: prevalence of lesions and association with scoliosis. J Bone Joint Surg Am. 2004;86-A(3):531\u20137.","journal-title":"J Bone Joint Surg Am"},{"key":"317_CR18","unstructured":"Boyce AM, Collins MT. Fibrous Dysplasia\/McCune-Albright Syndrome. In GeneReviews(R), Pagon RA, et al, Editors. 1993, University of Washington, Seattle: Seattle WA. This review contains specific diagnostic and treatment algorithms compiled from the highest quality evidenced-based literature and expert opinion currently available."},{"key":"317_CR19","doi-asserted-by":"crossref","unstructured":"Amit M et al. Surgery versus watchful waiting in patients with craniofacial fibrous dysplasia\u2014a meta-analysis. PLoS One. 2011;6(9):e25179. This meta-analysis establishes that prophylactic optic nerve decompression is contraindicated in patients with FD involving the optic canals without evidence of objective vision loss.","DOI":"10.1371\/journal.pone.0025179"},{"issue":"6","key":"317_CR20","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/lary.25078","volume":"125","author":"CD Frisch","year":"2015","unstructured":"Frisch CD et al. Fibrous dysplasia of the temporal bone: a review of 66 cases. Laryngoscope. 2015;125(6):1438\u201343.","journal-title":"Laryngoscope"},{"issue":"Suppl 1","key":"317_CR21","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1750-1172-7-S1-S4","volume":"7","author":"MT Collins","year":"2012","unstructured":"Collins MT, Singer FR, Eugster E. McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasia. Orphanet J Rare Dis. 2012;7 Suppl 1:S4.","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"317_CR22","doi-asserted-by":"crossref","first-page":"E1782","DOI":"10.1210\/jc.2012-1791","volume":"97","author":"AM Boyce","year":"2012","unstructured":"Boyce AM et al. Characterization and management of testicular pathology in McCune-Albright syndrome. J Clin Endocrinol Metab. 2012;97(9):E1782\u201390.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"317_CR23","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1210\/jc.2007-2237","volume":"93","author":"FS Celi","year":"2008","unstructured":"Celi FS et al. The role of type 1 and type 2 5\u2032-deiodinase in the pathophysiology of the 3,5,3\u2032-triiodothyronine toxicosis of McCune-Albright syndrome. J Clin Endocrinol Metab. 2008;93(6):2383\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"317_CR24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11914-013-0144-5","volume":"11","author":"AM Boyce","year":"2013","unstructured":"Boyce AM, Bhattacharyya N, Collins MT. Fibrous dysplasia and fibroblast growth factor-23 regulation. Curr Osteoporos Rep. 2013;11(2):65\u201371.","journal-title":"Curr Osteoporos Rep"},{"issue":"4","key":"317_CR25","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/jc.2009-2321","volume":"95","author":"RJ Brown","year":"2010","unstructured":"Brown RJ, Kelly MH, Collins MT. Cushing syndrome in the McCune-Albright syndrome. J Clin Endocrinol Metab. 2010;95(4):1508\u201315.","journal-title":"J Clin Endocrinol Metab"},{"key":"317_CR26","doi-asserted-by":"crossref","unstructured":"Boyce AM et al. Optic neuropathy in McCune-Albright syndrome: effects of early diagnosis and treatment of growth hormone excess. J Clin Endocrinol Metab. 2013;98(1):E126\u201334. This paper demonstrates that early diagnosis and treatment of growth hormone excess in FD\/MAS prevents long-term craniofacial morbidity.","DOI":"10.1210\/jc.2012-2111"},{"issue":"4","key":"317_CR27","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2106\/JBJS.E.00259","volume":"88","author":"AI Leet","year":"2006","unstructured":"Leet AI et al. The correlation of specific orthopaedic features of polyostotic fibrous dysplasia with functional outcome scores in children. J Bone Joint Surg Am. 2006;88(4):818\u201323.","journal-title":"J Bone Joint Surg Am"},{"issue":"5","key":"317_CR28","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/1097-0142(19940301)73:5<1411::AID-CNCR2820730516>3.0.CO;2-T","volume":"73","author":"P Ruggieri","year":"1994","unstructured":"Ruggieri P et al. Malignancies in fibrous dysplasia. Cancer. 1994;73(5):1411\u201324.","journal-title":"Cancer"},{"issue":"9","key":"317_CR29","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1210\/jc.2002-021642","volume":"88","author":"MT Collins","year":"2003","unstructured":"Collins MT et al. Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations. J Clin Endocrinol Metab. 2003;88(9):4413\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"317_CR30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF02966691","volume":"5","author":"Y Tanabeu","year":"1998","unstructured":"Tanabeu Y et al. Breast cancer in a patient with McCune-Albright syndrome. Breast Cancer. 1998;5(2):175\u20138.","journal-title":"Breast Cancer"},{"issue":"5","key":"317_CR31","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1075-122X.2004.21490.x","volume":"10","author":"TL Huston","year":"2004","unstructured":"Huston TL, Simmons RM. Ductal carcinoma in situ in a 27-year-old woman with McCune-Albright syndrome. Breast J. 2004;10(5):440\u20132.","journal-title":"Breast J"},{"issue":"92","key":"317_CR32","doi-asserted-by":"crossref","first-page":"92ra66","DOI":"10.1126\/scitranslmed.3002543","volume":"3","author":"J Wu","year":"2011","unstructured":"Wu J et al. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med. 2011;3(92):92ra66.","journal-title":"Sci Transl Med"},{"issue":"1","key":"317_CR33","doi-asserted-by":"crossref","first-page":"E97","DOI":"10.1210\/jc.2013-1823","volume":"99","author":"S Gaujoux","year":"2014","unstructured":"Gaujoux S et al. Hepatobiliary and pancreatic neoplasms in patients with McCune-Albright syndrome. J Clin Endocrinol Metab. 2014;99(1):E97\u2013101.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"317_CR34","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/jamasurg.2014.535","volume":"149","author":"A Parvanescu","year":"2014","unstructured":"Parvanescu A et al. Lessons from McCune-Albright syndrome-associated intraductal papillary mucinous neoplasms: GNAS-activating mutations in pancreatic carcinogenesis. JAMA Surg. 2014;149(8):858\u201362.","journal-title":"JAMA Surg"},{"issue":"5","key":"317_CR35","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","volume":"112","author":"M Riminucci","year":"2003","unstructured":"Riminucci M et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest. 2003;112(5):683\u201392.","journal-title":"J Clin Invest"},{"issue":"11","key":"317_CR36","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1359\/jbmr.080609","volume":"23","author":"SA Kuznetsov","year":"2008","unstructured":"Kuznetsov SA et al. Age-dependent demise of GNAS-mutated skeletal stem cells and \u201cnormalization\u201d of fibrous dysplasia of bone. J Bone Miner Res. 2008;23(11):1731\u201340.","journal-title":"J Bone Miner Res"},{"issue":"5","key":"317_CR37","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/jbmr.1546","volume":"27","author":"N Bhattacharyya","year":"2012","unstructured":"Bhattacharyya N et al. Mechanism of FGF23 processing in fibrous dysplasia. J Bone Miner Res. 2012;27(5):1132\u201341.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"317_CR38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11832-007-0006-8","volume":"1","author":"AI Leet","year":"2007","unstructured":"Leet AI, Collins MT. Current approach to fibrous dysplasia of bone and McCune-Albright syndrome. J Child Orthop. 2007;1(1):3\u201317.","journal-title":"J Child Orthop"},{"key":"317_CR39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bone.2013.11.022","volume":"60","author":"SM Paul","year":"2014","unstructured":"Paul SM et al. Disease severity and functional factors associated with walking performance in polyostotic fibrous dysplasia. Bone. 2014;60:41\u20137.","journal-title":"Bone"},{"key":"317_CR40","doi-asserted-by":"crossref","unstructured":"Leet AI et al. Bone-grafting in polyostotic fibrous dysplasia. J Bone Joint Surg Am. 2016;98(3):211\u20139. This study demonstrates that the common surgical practice of bone grafting is frequently ineffective in patients with FD, particularly children.","DOI":"10.2106\/JBJS.O.00547"},{"issue":"Suppl 1","key":"317_CR41","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1750-1172-7-S1-S1","volume":"24","author":"RP Stanton","year":"2012","unstructured":"Stanton RP, Ippolito E, Springfield D, Lindaman L, Wientroub S, Leet A. The surgical management of fibrous dysplasia of bone. Orphanet J Rare Dis. 2012;24 Suppl 1:S1.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"317_CR42","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s00586-008-0860-1","volume":"18","author":"F Mancini","year":"2009","unstructured":"Mancini F et al. Scoliosis and spine involvement in fibrous dysplasia of bone. Eur Spine J. 2009;18(2):196\u2013202.","journal-title":"Eur Spine J"},{"issue":"6","key":"317_CR43","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/PRS.0b013e31828bd70c","volume":"131","author":"JS Gabbay","year":"2013","unstructured":"Gabbay JS et al. Fibrous dysplasia of the zygomaticomaxillary region: outcomes of surgical intervention. Plast Reconstr Surg. 2013;131(6):1329\u201338.","journal-title":"Plast Reconstr Surg"},{"key":"317_CR44","doi-asserted-by":"crossref","unstructured":"Lee J, Fitzgibbon E, Chen Y, Kim H, Lustig L, Akintoye S, Collins M, Kaban L. Clinical guidelines for the management of craniofacial fibrous dysplasia. 2012. 24 Suppl 1:S2(7): p. Suppl 1:S2.","DOI":"10.1186\/1750-1172-7-S1-S2"},{"issue":"21","key":"317_CR45","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJMoa020742","volume":"347","author":"JS Lee","year":"2002","unstructured":"Lee JS et al. Normal vision despite narrowing of the optic canal in fibrous dysplasia. N Engl J Med. 2002;347(21):1670\u20136.","journal-title":"N Engl J Med"},{"key":"317_CR46","doi-asserted-by":"crossref","unstructured":"Boyce AM et al. A randomized, double blind, placebo-controlled trial of alendronate treatment for fibrous dysplasia of bone. J Clin Endocrinol Metab. 2014;99(11):4133\u201340. This study reports the first randomized controlled trial in FD, demonstrating that oral alendronate is ineffective in improving FD-related pain or the radiographic appearance of FD lesions.","DOI":"10.1210\/jc.2014-1371"},{"issue":"1","key":"317_CR47","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bone.2004.03.004","volume":"35","author":"RD Chapurlat","year":"2004","unstructured":"Chapurlat RD et al. Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment. Bone. 2004;35(1):235\u201342.","journal-title":"Bone"},{"issue":"8903","key":"317_CR48","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0140-6736(94)90069-8","volume":"343","author":"D Liens","year":"1994","unstructured":"Liens D, Delmas PD, Meunier PJ. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet. 1994;343(8903):953\u20134.","journal-title":"Lancet"},{"issue":"10","key":"317_CR49","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1210\/jc.2003-030050","volume":"88","author":"H Plotkin","year":"2003","unstructured":"Plotkin H et al. Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone. J Clin Endocrinol Metab. 2003;88(10):4569\u201375.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"317_CR50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00198-007-0425-x","volume":"19","author":"MH Kelly","year":"2008","unstructured":"Kelly MH, Brillante B, Collins MT. Pain in fibrous dysplasia of bone: age-related changes and the anatomical distribution of skeletal lesions. Osteoporos Int. 2008;19(1):57\u201363.","journal-title":"Osteoporos Int"},{"key":"317_CR51","doi-asserted-by":"crossref","unstructured":"Salenave S. et al. Acromegaly and McCune-Albright syndrome. J Clin Endocrinol Metab, 2014: p. jc20133826.","DOI":"10.1210\/jc.2013-3826"},{"issue":"3","key":"317_CR52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000342641","volume":"78","author":"D Tessaris","year":"2012","unstructured":"Tessaris D et al. Thyroid abnormalities in children and adolescents with McCune-Albright syndrome. Horm Res Paediatr. 2012;78(3):151\u20137.","journal-title":"Horm Res Paediatr"},{"issue":"4","key":"317_CR53","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1073\/pnas.0707457105","volume":"105","author":"EC Hsiao","year":"2008","unstructured":"Hsiao EC et al. Osteoblast expression of an engineered Gs-coupled receptor dramatically increases bone mass. Proc Natl Acad Sci U S A. 2008;105(4):1209\u201314.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"317_CR54","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/jbmr.3","volume":"25","author":"EC Hsiao","year":"2010","unstructured":"Hsiao EC et al. Gs G protein-coupled receptor signaling in osteoblasts elicits age-dependent effects on bone formation. J Bone Miner Res. 2010;25(3):584\u201393.","journal-title":"J Bone Miner Res"},{"issue":"11","key":"317_CR55","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1002\/jbmr.2267","volume":"29","author":"I Saggio","year":"2014","unstructured":"Saggio I et al. Constitutive expression of Gsalpha(R201C) in mice produces a heritable, direct replica of human fibrous dysplasia bone pathology and demonstrates its natural history. J Bone Miner Res. 2014;29(11):2357\u201368.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"317_CR56","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nm.3028","volume":"19","author":"P Bianco","year":"2013","unstructured":"Bianco P et al. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med. 2013;19(1):35\u201342.","journal-title":"Nat Med"},{"issue":"3","key":"317_CR57","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/ten.teb.2013.0578","volume":"20","author":"H Kagami","year":"2014","unstructured":"Kagami H et al. The use of bone marrow stromal cells (bone marrow-derived multipotent mesenchymal stromal cells) for alveolar bone tissue engineering: basic science to clinical translation. Tissue Eng Part B Rev. 2014;20(3):229\u201332.","journal-title":"Tissue Eng Part B Rev"},{"key":"317_CR58","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bone.2014.07.020","volume":"70","author":"PG Robey","year":"2015","unstructured":"Robey PG et al. Generation of clinical grade human bone marrow stromal cells for use in bone regeneration. Bone. 2015;70:87\u201392.","journal-title":"Bone"},{"issue":"1","key":"317_CR59","doi-asserted-by":"crossref","first-page":"54","DOI":"10.15283\/ijsc.2015.8.1.54","volume":"8","author":"N Kim","year":"2015","unstructured":"Kim N, Cho SG. New strategies for overcoming limitations of mesenchymal stem cell-based immune modulation. Int J Stem Cells. 2015;8(1):54\u201368.","journal-title":"Int J Stem Cells"},{"issue":"3","key":"317_CR60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090766","volume":"9","author":"N Bhattacharyya","year":"2014","unstructured":"Bhattacharyya N et al. A high throughput screening assay system for the identification of small molecule inhibitors of gsp. PLoS One. 2014;9(3), e90766.","journal-title":"PLoS One"},{"issue":"3","key":"317_CR61","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.clinthera.2012.02.002","volume":"34","author":"DW Dempster","year":"2012","unstructured":"Dempster DW et al. Role of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data. Clin Ther. 2012;34(3):521\u201336.","journal-title":"Clin Ther"},{"key":"317_CR62","unstructured":"Prolia [package insert]. Thousand Oaks, CA., 2010. Amgen, Inc."},{"key":"317_CR63","unstructured":"Xgeva [package insert]. Thousand Oaks, CA., 2010. Amgen, Inc."},{"issue":"5","key":"317_CR64","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.3747\/co.20.1497","volume":"20","author":"SF Xu","year":"2013","unstructured":"Xu SF et al. Denosumab and giant cell tumour of bone\u2014a review and future management considerations. Curr Oncol. 2013;20(5):e442\u20137.","journal-title":"Curr Oncol"},{"key":"317_CR65","first-page":"69","volume":"9","author":"AS Singh","year":"2015","unstructured":"Singh AS, Chawla NS, Chawla SP. Giant-cell tumor of bone: treatment options and role of denosumab. Biologics. 2015;9:69\u201374.","journal-title":"Biologics"},{"issue":"3","key":"317_CR66","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1470-2045(10)70010-3","volume":"11","author":"D Thomas","year":"2010","unstructured":"Thomas D et al. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol. 2010;11(3):275\u201380.","journal-title":"Lancet Oncol"},{"issue":"3","key":"317_CR67","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1210\/jc.2013-3081","volume":"99","author":"HD Wang","year":"2014","unstructured":"Wang HD et al. Effects of denosumab treatment and discontinuation on human growth plates. J Clin Endocrinol Metab. 2014;99(3):891\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"317_CR68","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jbspin.2014.04.013","volume":"81","author":"J Benhamou","year":"2014","unstructured":"Benhamou J, Gensburger D, Chapurlat R. Transient improvement of severe pain from fibrous dysplasia of bone with denosumab treatment. Joint Bone Spine. 2014;81(6):549\u201350.","journal-title":"Joint Bone Spine"},{"issue":"7","key":"317_CR69","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/jbmr.1603","volume":"27","author":"AM Boyce","year":"2012","unstructured":"Boyce AM et al. Denosumab treatment for fibrous dysplasia. J Bone Miner Res. 2012;27(7):1462\u201370.","journal-title":"J Bone Miner Res"},{"issue":"6","key":"317_CR70","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/pbc.25393","volume":"62","author":"N Gossai","year":"2015","unstructured":"Gossai N et al. Critical hypercalcemia following discontinuation of denosumab therapy for metastatic giant cell tumor of bone. Pediatr Blood Cancer. 2015;62(6):1078\u201380.","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"317_CR71","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1210\/jc.2013-1143","volume":"98","author":"C Grasemann","year":"2013","unstructured":"Grasemann C et al. Effects of RANK-ligand antibody (denosumab) treatment on bone turnover markers in a girl with juvenile Paget\u2019s disease. J Clin Endocrinol Metab. 2013;98(8):3121\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"317_CR72","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00774-015-0677-z","volume":"34","author":"N Setsu","year":"2016","unstructured":"Setsu N et al. Severe hypercalcemia following denosumab treatment in a juvenile patient. J Bone Miner Metab. 2016;34(1):118\u201322.","journal-title":"J Bone Miner Metab"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-016-0317-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11914-016-0317-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-016-0317-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T17:45:42Z","timestamp":1718732742000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11914-016-0317-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,4]]},"references-count":72,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["317"],"URL":"https:\/\/doi.org\/10.1007\/s11914-016-0317-0","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,4]]}}}